Clariane Shares Dip at Close: Chart Support Under Watch
European dependency care specialist Clariane's stock fell on Wednesday, January 28, closing down 1.73% at 3.97 euros, breaking from a previously favorable weekly trend.
Today's session marks a pause in Clariane's recent trajectory. After a weekly increase of 2.48%, the stock fell below 4 euros, losing nearly 2% in a single session. Over three months, the decline reaches 11.66%, indicating a phase of consolidation after a spectacular recovery over the year: the stock still shows a 75.82% increase over the past twelve months, demonstrating a long-term return to favor. The volatility remains contained, measured at 9.54 over a month, a level that allows for sudden movements but without excessive panic. Today's movement thus occurs in a technical framework where oscillations remain measured, offering investors relative visibility in a sector structurally monitored for its exposure to public funding issues and regulation.
Technical Analysis Perspective
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
From a graphical perspective, the stock now trades slightly above its 20-day moving average, established at 3.89 euros. This positioning reflects proximity to a psychological and technical threshold. The recent crossing of this average had indicated a resurgence of buyer interest, but today's decline brings the price back to just a few cents above this pivotal zone. The 14-day Relative Strength Index (RSI) stands at 59, an intermediate level that excludes any overheating or overselling signals. This configuration indicates indecision: the stock is neither in a zone of extreme risk nor in a phase of clear acceleration. The upcoming sessions will be crucial to confirm or refute the maintenance above the moving average, a cornerstone of the short-term dynamic.
SectorServices et infrastructure de santé›Etablissements de santé / EHPAD
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: S1 2026
Key reported figures
Revenue: 2 699 millions d'euros
Quarterly revenue: 2 699 millions d'euros
Revenue growth: 1,6 %
EBITDA: 524 millions d'euros
EBITDA margin: 10,4 %
Net income: -47,5 millions d'euros
Free cash flow: 20 millions d'euros
3 020 millions d'euros
Guidance from the release
Le Groupe s'appuiera principalement sur la poursuite de l'amélioration de la performance opérationnelle et le maintien d'une stricte discipline d'investissements
Risks mentioned
Environnement géopolitique complexe affectant les opérations de refinancement
Exposition aux épisodes climatiques frappant durement certains territoires en Europe
Pression inflationniste continue sur les coûts opérationnels malgré les gains tarifaires
Opportunities identified
Amélioration de la marge EBITDA de 100-150 points de base d'ici fin 2026
Croissance des volumes d'activité portée par l'augmentation progressive des taux d'occupation
Refinancement réussi de €1 063m renforçant la flexibilité financière et réduisant le coût de la dette
Outlook / guidance
Expected revenue: 5 522 millions d'euros
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.